Submit Content
Get the latest delivered to your inbox
Privacy Policy

Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

    Prioritizing the Needs of the Black LGBTQ+ Community in an Innovative HIV Trial Image

    POSTED 

    07-27-21

    Prioritizing the Needs of the Black LGBTQ+ Community in an Innovative HIV Trial

    Dr. Theo Hodge, a physician and infectious disease expert with the Washington Health Institute in Washington, D.C., is all too familiar with the disproportionate impact HIV has on the Black LGBTQ+ community. He knows that one of every two Black gay, bi and other men who have sex with men in the Unit...
    Adonis Timone Aims to Create Change With Advocates for Youth Image

    POSTED 

    06-22-21

    Adonis Timone Aims to Create Change With Advocates for Youth

    Adonis Timone may be best known for their rap music, but the young, gender nonbinary artist who identifies with the pronouns he/they also works in the areas of HIV outreach and advocacy.
    It's Time to Pass the Equality Act Image

    POSTED 

    06-15-21

    It's Time to Pass the Equality Act

    Passing the Equality Act is a necessary step toward protecting members of the LGBTQ+ community – but it is not enough. Gilead strongly opposes the myriad legislative efforts currently underway in many jurisdictions around the United States
    Lance Toma Creates Safe Spaces for San Francisco's LGBTQ+ AAPI Community Image

    POSTED 

    06-03-21

    Lance Toma Creates Safe Spaces for San Francisco's LGBTQ+ AAPI Community

    Lance Toma was looking for community. Raised in Hawaii, he came out as gay when he moved to Chicago as an adult and found work serving LGBTQ+ youth and adults there.
    Four Questions With Wayne Duffus: Addressing Health Disparities in HIV Prevention and Care Image

    POSTED 

    05-27-21

    Four Questions With Wayne Duffus: Addressing Health Disparities in HIV Prevention and Care

    When Wayne Duffus moved from Jamaica to New York after high school, he quickly developed an interest in science thanks to a handful of inspiring mentors.
    A Workplace for Tomorrow Image

    POSTED 

    05-19-21

    A Workplace for Tomorrow

    When Gilead set out to design a new research building, the company had big aspirations. The aim was to build a space that would encourage researchers to focus on their scientific visions of tomorrow.
    Committed to Reducing Greenhouse Gas Emissions for a Healthier World Image

    POSTED 

    04-24-20

    Committed to Reducing Greenhouse Gas Emissions for a Healthier World

    Stories @ Gilead

    Gilead views environmental stewardship as critical to help the company achieve its mission and last year announced a goal to reduce gr...

    Ramping Up Manufacturing to Help Address COVID-19 Image

    POSTED 

    04-14-20

    Ramping Up Manufacturing to Help Address COVID-19

    As the number of confirmed COVID-19 cases increased in Asia and began to spread to other regions around the world, a team of employees at Gilead’s manufacturing site in La Verne, California met in the early morning of Monday, Feb. 3.

    The topic of the meeting: How quickly could the site beg...

    An Open Letter from our Chairman and CEO Image

    POSTED 

    04-02-20

    An Open Letter from our Chairman and CEO

    Daniel O'Day

    When the news of the coronavirus first emerged, Gilead immediately began to investigate the potential of remdesivir, a medicine we had been studying for many years as part of our extensive research in antivirals. Remdesivir had never been approved for use but based on...

    Gilead Sciences Statement on Ensuring Continued Supply of HIV Medicine Amid Coronavirus Outbreak Image

    POSTED 

    03-25-20

    Gilead Sciences Statement on Ensuring Continued Supply of HIV Medicine Amid Coronavirus Outbreak

    For those with potentially immunosuppressing conditions, such as HIV, the uncertainty caused by the novel coronavirus pandemic can be particularly challenging. Gilead remains focused on ensuring that people living with or at risk for HIV have access to the medications and ...

    Gilead Sciences Logo

    Gilead Sciences

    Gilead Sciences

    Join today and get the latest delivered to your inbox